TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Equivalence of administration formats of the IPAB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement with interactive text messages
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: HsCRP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Gal‐3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Upper respiratory tract symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: minutes of moderate to vigorous physical activity (MVPA) per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proarrhythmic effect
Endpoint domain: Adverse events/effects
Primary endpoint: VAS activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weighted mean plasma glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of obesity-related cancers
Endpoint domain: Mortality/survival
Primary endpoint: global PSQI score change
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: small intestinal mucosal injury scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: number of rescue analgesics taken
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CSF amyloid beta (Aβ)42/40 ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total tau (t‐tau)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surround suppression of visual contrast detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of life after HIPEC
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: self-assessed satisfaction ratings of cosmetic outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: venous clinical severity scores (VCSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hyperpigmentation and trapped blood
Endpoint domain: Adverse events/effects
Primary endpoint: serum total folate concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: UMFA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 5-methylTHF concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: gait efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion rates for Ab, IgM and IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median seroconversion time post exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of antibodies (Ab, IgM, IgG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improved oral health-related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Eligibility criteria met for RCTs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: levels of functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: levels of dyspnoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Procedure-related Cardiac Events (PoCE)
Endpoint domain: Mortality/survival
Primary endpoint: dorsiflexor bursts during swing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plantarflexor stance activity duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dorsiflexor on/off time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Membrane rupture to delivery interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal satisfaction visual numerical rating score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Iron bioavailability from fortified infant cereals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: clinical cure rates at day 10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients with no signs or symptoms at day 25
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: requirement for antifungal rescue medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of falls experienced
Endpoint domain: Adverse events/effects
Primary endpoint: Poor walking abilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoliosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Trunk muscles' tone disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Poor motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: one-card learning accuracy impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: One-back memory impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: complications (respiratory depression and hypotension)
Endpoint domain: Adverse events/effects
Primary endpoint: Early implant failure
Endpoint domain: Mortality/survival
Primary endpoint: Mental health functioning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-intubation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month cumulative incidence rate of major symptomatic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month cumulative incidence rate of minor symptomatic episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved staff satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved mother satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Health benefits for mothers and newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient timeliness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Shoulder rotation range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder external rotator strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep pattern improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Amount of soft plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity of proteolytic enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of postoperative delirium (POD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preoperative plasma levels of CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's appetite
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: parent-child relationship
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intracranial infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Intensity of fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: ΔE (color change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvements in kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of preterm infants with a R‐PIPP score ≤12 during LISA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of forearm hematoma grade ≥ 2
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of radial artery occlusion (RAO)
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in mental health literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: facilitation of symptom recognition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: alleviation of help-seeking barriers
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Mayo scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-23 and IL-17 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cardiac remodelling (IVS, PW, RWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early diastolic dysfunction (e prime)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Primary technical success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functionally maturation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Primary and secondary patency rates at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum plasma varenicline concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Areas under the concentration‐time curve (AUC0‐t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: time of awakening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of injection pain during induction
Endpoint domain: Adverse events/effects
Primary endpoint: intraoperative hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Total antibiotic prescribing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric knee flexion peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postprandial blood glycerol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Subclinical lymphedema identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TEG parameters (R value and MA value)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Absolute difference in ODI after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in disease knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in autism symptom severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of finger flexion and extension
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of tendon rupture and adhesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: salivary HNP1-3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S. mutans levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: caries progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPI index at 6 months after delivery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of local tumor progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Laryngoscopy grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum PAB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: contracted thickness of TrA and Gmax muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Rate of seizure freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: plank persistence times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rADR (rate of adenoma detection)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: rSLDR (rate of successful lesion detection)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improved continence measured with the ICIQ‐SF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Agreement with the gold standard for abnormal or normal disc
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for smartphone over direct ophthalmoscopy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in optic disc interpretation scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healthcare situation improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: health literacy improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in Attention/Vigilance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Range of Motion (ROM) of knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital for Special Surgery Score (HSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Convenience of care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Cardiorespiratory stabilisation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with migraine headache on the first day after injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean transmitral gradient at peak exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Moderate mitral regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6-minute walking distance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Death prior to day 28
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in plasmablasts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum immunoglobulin levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in NRSs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Improvement in spasticity on the Modified Ashworth Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Improvement in mobility outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Orienteering performance time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in resilience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in ST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event rates for all infections
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of hospitalization for infection
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of a first cardiovascular event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SPO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Borg Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spontaneous preterm birth rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: greater amyloid burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Natural delivery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean post-test scores of prenatal attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Development of positive SARS-COV-2 IgG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median IgG titer 1 month following the third dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: emotional arousal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 90-day good functional outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum Inhibitory Concentration (MIC) of cefazolin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: FSST increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: plasma bicarbonate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary ammonium excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Professional satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Isokinetic peak strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBW-adjusted dexmedetomidine loading dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutropenia (adverse event)
Endpoint domain: Adverse events/effects
Primary endpoint: muscle weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change of the MDS‐UPDRS‐I
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PICC failure per 1000 PICC days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average dwell time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sNfL cut-off value for long-term disability progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in CAN risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fractional exhaled nitric oxide (FeNO) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Haptoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in scores of PHQ-9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in scores of GAD-7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in scores of LDQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of biopsy-proven acute rejection (BPAR)
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative outcomes of decompression surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uptake of HIV prevention services
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-efficacy in HIV prevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deaths as a result of bleeding
Endpoint domain: Mortality/survival
Primary endpoint: BRIEF-2 domains
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Salivary S. mutans count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Participants' experiences of MI sessions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perceived range of motion in foot and ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of discomfort in foot and ankle joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provider detection rates for substance use disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to identify cognitions and perceptions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ability to recommend evidence-based interventions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Surgical field assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Estimates of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extracorporeal membrane oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduced incidence of cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Differential IOP measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes